INRD yields 183.49% · MRK yields 2.76%● Live data
📍 INRD pulled ahead of the other in Year 1
Combined, INRD + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INRD + MRK for your $10,000?
Inrad Optics, Inc., together with its subsidiaries, develops, manufactures, and markets crystal-based optical components and devices, custom optical components, and precision optical and opto-mechanical assemblies worldwide. The company provides optical components, optical coatings, and subassemblies; and UV filter optical components for use in critical applications in defense systems, such as missile warning sensors, as well as opto-mechanical design and assembly services. Its optical components include planar, prismatic, and spherical components fabricated from glass and synthetic crystals; and various components consist of large form factor transmission flats, optical windows for airborne applications, multi-element optical assemblies, lenses, mirrors, polarizing optics, prisms, wave plates, and x-ray monochromators. The company also offers laser devices and instrumentation products comprising electro-optic and nonlinear crystal devices for altering the intensity, polarization, or wavelength of a laser beam, as well as other crystal components for use in laser research, in commercial laser systems, and in detection of fast neutrons; and pockels' cells and associated electronics. It also serves corporations in the laser system, process control, and metrology sectors of the photonics industry, as well as the United States Government, national laboratories, universities, and institutions. The company markets its products through sales, marketing, and customer service teams, as well as through independent sales agents. Inrad Optics, Inc. also exports its products Europe, Israel, and Asia. The company was formerly known as Photonic Products Group, Inc. and changed its name to Inrad Optics, Inc. in 2012. Inrad Optics, Inc. was incorporated in 1973 and is based in Northvale, New Jersey.
Full INRD Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.